D-0454-2024 Class I Ongoing
FDA drug recall D-0454-2024 was initiated by Pyramids Wholesale Inc. on March 19, 2024 and is designated Class I. Reason for recall: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil. The recall status is ongoing. Affected quantity: 7 boxes.
Recall Details
- Product Type
- Drugs
- Report Date
- May 1, 2024
- Initiation Date
- March 19, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7 boxes
Product Description
libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
Reason for Recall
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution Pattern
Nationwide in the USA
Code Information
All lots